Mayne Pharma is suing a former suitor, with reports indicating the lawsuit is related to costs associated with a failed bid. The case appears to be ongoing, with a judge having previously expressed frustration over the suitor's reluctance to pay a significant legal bill. The failed bid was reportedly blocked on national interest grounds.